1
00:00:00,000 --> 00:00:03,500
Semax research includes experiments on brain signalling.

2
00:00:03,500 --> 00:00:10,583
A 2006 study measured BDNF-related changes in the rat hippocampus, a brain region involved in learning

3
00:00:10,583 --> 00:00:14,083
and memory.

4
00:00:14,083 --> 00:00:18,750
A change in a signalling protein can suggest a mechanism.

5
00:00:18,750 --> 00:00:25,417
It does not, by itself, show better memory or a useful treatment effect in people.

6
00:00:25,417 --> 00:00:30,875
FDA’s July 2026 briefing found insufficient effectiveness evidence for Semax-related substances in

7
00:00:30,875 --> 00:00:34,375
cerebral ischemia, migraine and trigeminal neuralgia.

8
00:00:34,375 --> 00:00:37,875
That assessment concerns specific proposed uses.

9
00:00:37,875 --> 00:00:41,750
The same briefing raises product-characterization and safety concerns.

10
00:00:41,750 --> 00:00:48,417
Keep the exact substance, study population and clinical outcome visible when assessing a claim about

11
00:00:48,417 --> 00:00:51,917
Semax.